Four cardiothoracic surgeons discuss the opioid epidemic in the United States, the scope of the problem among lung cancer patients, how else the epidemic is affecting the cardiothoracic surgery community, and what cardiothoracic surgeons are doing to stem the crisis.

Keith S. Naunheim, MD (Saint Louis University) - moderator
David T. Cooke, MD (UC Davis, Sacramento)
James D. Luketich, MD (University of Pittsburgh)
Alexander A. Brescia, MD (University of Michigan)

New technologies and innovative treatments are making it easier to successfully diagnose and treat patients with lung cancer. Douglas E. Wood, MD (University of Washington) moderates a discussion with Leah Backhus, MD, MPH (Stanford University), Elizabeth David, MD (UC Davis), and Moishe Liberman, MD, PhD (University of Montreal) about how low-dose computed tomography, wearable devices, energy-sealing devices, and robots are changing patient outcomes and experiences.

The volumes of two aortic valve replacements (AVR) procedures have changed dramatically over the past few years, with more transcatheter procedures now being performed than open surgical procedures. Four cardiac surgeons discuss the evolving trends in TAVR, why the changes are occurring, and what’s ahead for TAVR and SAVR. Wilson Y. Szeto, MD (University of Pennsylvania) moderates the discussion that also features Michael J. Mack, MD (The Heart Hospital Baylor Plano), John V. Conte, MD (Penn State University), and Thomas E. MacGillivray, (Houston Methodist).

Mentorship is an important component to success for many up-and-coming cardiothoracic surgeons. For established surgeons, being a good mentor is equally as important. Vinay Badhwar, MD (West Virginia University) moderates a discussion that includes Shanda H. Blackmon, MD, MPH (Mayo Clinic), Melanie A. Edwards, MD (Saint Louis University), and David D. Odell, MD, MMSc (Northwestern University) talking about how mentorship is critical to the future of the specialty and what STS is doing to promote mentorship for early career surgeons.

The latest advances in mitral valve repair and replacement include a shift toward the transseptal platform. Four leading experts discuss how catheter-based techniques will re-emulate the gold standard for mitral valve surgery, the important role of 3D Echo technology, the need for transseptal puncture skills, and navigating the local politics. 

Health care professionals tend to be traditional and conservative when it comes to practice, so incorporating new technologies and innovations into the hospital and the operating room can be a challenge. Four cardiothoracic surgery change drivers — Shanda Blackmon, MD, MPH (Mayo Clinic), James Luketich, MD (UPMC Presbyterian), T. Sloan Guy, MD, MBA (Weill Cornell Medical Medicine), and Linda W. Martin, MD, MPH (University of Virginia) — provide advice on how to get buy-in from hospital administrators, as well as team members.

Two studies presented at the recent STS Annual Meeting showed that surgical therapy is superior to alternative treatment approaches for both esophageal cancer and coronary artery disease in younger patients. In light of these findings, Robbin G. Cohen, MD, MMM (University of Southern California), Mark S. Allen, MD (Mayo Clinic), Sebron W. Harrison, MD (Weill-Cornell Medicine), and Alan M.

On average, it takes 17 years before new innovation is disseminated into clinical practice. How can cardiothoracic surgery change that statistic and speed up the process? Juan A. Sanchez, MD (St. Agnes HealthCare Baltimore) moderates a discussion with Michael S.

Should patients remain active before, during, and after cardiac surgery? Some surgeons have opposing views. Thomas G. Gleason, MD, from the University of Pittsburgh, and Edward P. Chen, MD, from Emory University, discuss the role of exercise in the treatment and recovery process following surgery for various forms of heart disease, especially among active patients.